What is 60 Degrees Pharmaceuticals Inc (SXTP)?

60 Degrees Pharmaceuticals Inc (SXTP) Stock Analysis

$1.030

-0.029 (-2.83%)At close

Loading chart…

High: 1.120
Open: 1.090
VWAP: 1.05
Vol: 23.94K
Mkt Cap: 3.28M
Low: 1.010
Amount: 25.22K
EV/EBITDA, TTM: 0.00

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

60degreespharma.com

Valuation Metrics

The current forward P/E ratio for 60 Degrees Pharmaceuticals Inc (SXTP) is -0.14, compared to its 5-year average forward P/E of -0.88.

Forward P/E

Fair

5Y Average P/E

-0.88

Current P/E

-0.14

Overvalued

-0.02

Undervalued

-1.74

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Fair

5Y Average P/S

4.84

Current P/S

1.47

Overvalued

10.59

Undervalued

-0.91

Alphio AI Price Scenarios for SXTP

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%SXTP

$4.69

Scenario price

Base

Base · 50%SXTP

$4.56

Scenario price

Bear

Bear · 25%SXTP

$4.10

Scenario price

Events Timeline

2026-07-30 (ET)